Vena Cava Thrombosis After Vena Cava Filter Placement: Incidence and Risk Factors

Overview

Journal J Geriatr Cardiol

Specialty Geriatrics

Date 2012 Jul 12

PMID 22783293

Citations 3

Authors

Ya-Juan Guo

Jun Feng

Tian-Rong Qu

Yan Qu

Ya-Min Liu

Yu-Shun Zhang

Hong-Yan Tian

Ai-Qun Ma

Affiliations

Soon will be listed here.

Abstract

Background: The objective of this study was to assess the clinical safety and efficacy of vena cava filter (VCF) placement, with particular emphasis on the incidence and risk factors of inferior vena cava thrombosis (VCT) after VCF placement.

Methods: Clinical data of patients with venous thromboembolism (VTE), with or without placement of VCF, were analyzed in a retrospective single-center audit of medical records from January 2005 to June 2009. The collected data included demographics, procedural details, filter type, indications, and complications.

Results: A total of 168 cases of VTE (82 with VCF; 86 without VCF) were examined. Over a median follow-up of 24.2 months, VCT occurred in 18 of 82 patients with VCFs (11 males, 7 females, mean age 55.4 years). In 86 patients without VCFs, VCT occurred in only 6 individuals (4 males, 2 females) during the study period. VCT was observed more frequently in patients fitted with VCFs than in those without VCFs (22% vs. 7.0%).

Conclusions: The incidence of VCT in patients with VTE after VCF implantation was 22% approximately. Anticoagulation therapy should be continued for all patients with VCF placement, unless there is a specific contraindication. Almost all instances of VCT in patients with VCF implants in our study occurred after stopping anticoagulation treatment. The use of VCFs is increasing, and more trials are needed to confirm their benefit and accurately assess their safety.

Citing Articles

Acute caval thrombosis leading to obstructive shock in the early post insertion period of an inferior vena cava filter: a case report and literature review.

Gao S, Chen Y, Huang Y, Dang Y, Li Y Thromb J. 2024; 22(1):7.

PMID: 38200597 PMC: 10777529. DOI: 10.1186/s12959-023-00567-3.

Phlegmasia cerulea dolens: a rare cause of shock.

Lewis C, Hensley M, Barrett J, Van Norman S, Taylor A, Horowitz J Respirol Case Rep. 2019; 7(5):e00424.

PMID: 30997109 PMC: 6452327. DOI: 10.1002/rcr2.424.

[Vena cava filter. Which indications remain in the era of differentiated anticoagulation?].

Mahnken A Radiologe. 2013; 53(3):209-15.

PMID: 23429797 DOI: 10.1007/s00117-012-2418-9.

References

Martin M, Blair K, Curry T, Singh N . Vena cava filters: current concepts and controversies for the surgeon. Curr Probl Surg. 2010; 47(7):524-618. DOI: 10.1067/j.cpsurg.2010.03.004. View

Ye W, Liu C, Liu B, Zheng Y, Li Y, Li J . [Safety and efficiency of non-permanent inferior vena cava filters in preventing pulmonary embolism]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007; 29(1):55-8. View

Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P . A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998; 338(7):409-15. DOI: 10.1056/NEJM199802123380701. View

Patel S, Patel R . Inferior vena cava filters for recurrent thrombosis: current evidence. Tex Heart Inst J. 2007; 34(2):187-94. PMC: 1894721. View

Corriere M, Sauve K, Suave K, Ayerdi J, Craven B, Stafford J . Vena cava filters and inferior vena cava thrombosis. J Vasc Surg. 2007; 45(4):789-94. DOI: 10.1016/j.jvs.2006.12.048. View

Buller H, Agnelli G, Hull R, Hyers T, Prins M, Raskob G . Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3 Suppl):401S-428S. DOI: 10.1378/chest.126.3_suppl.401S. View

Young T, Tang H, Hughes R . Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev. 2010; (2):CD006212. PMC: 7387443. DOI: 10.1002/14651858.CD006212.pub4. View

Nicholson W, Nicholson W, Tolerico P, Taylor B, Solomon S, Schryver T . Prevalence of fracture and fragment embolization of Bard retrievable vena cava filters and clinical implications including cardiac perforation and tamponade. Arch Intern Med. 2010; 170(20):1827-31. DOI: 10.1001/archinternmed.2010.316. View

White R . The epidemiology of venous thromboembolism. Circulation. 2003; 107(23 Suppl 1):I4-8. DOI: 10.1161/01.CIR.0000078468.11849.66. View

10.

Joels C, Sing R, Heniford B . Complications of inferior vena cava filters. Am Surg. 2003; 69(8):654-9. View

11.

Seshadri T, Tran H, Lau K, Tan B, Gan T . Ins and outs of inferior vena cava filters in patients with venous thromboembolism: the experience at Monash Medical Centre and review of the published reports. Intern Med J. 2007; 38(1):38-43. DOI: 10.1111/j.1445-5994.2007.01478.x. View

12.

. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005; 112(3):416-22. DOI: 10.1161/CIRCULATIONAHA.104.512834. View

13.

Kinney T . Update on inferior vena cava filters. J Vasc Interv Radiol. 2003; 14(4):425-40. DOI: 10.1097/01.rvi.0000064860.87207.77. View